Biocon Limited reported earnings results for the third quarter and nine months ended December 31, 2011. For the quarter, company has posted a net profit of INR 848.50 million as compared to INR 1,007.60 million for the quarter ended December 31, 2010. Total income has increased from INR 5,184.40 million for the quarter ended December 31, 2010 to INR 5,321.80 million. The company reported a 16% fall year on year in net profit for the quarter, resulting from a sharp slowdown in licensing income. Earnings per share fell to INR 4.20 from INR 5 reported a year ago. Revenues registered a marginal growth of 3% to reach INR 5.32 billion against INR 5.19 billion a year ago. Net sales were up by 1% to INR 5.17 billion. Ebitda also took a beating, falling by 17% year on year to INR 1.42 billion, with margins of 27%, compared with INR 1.71 billion reported a year ago. The company reported profit after tax growth of 29% for the nine month ended December 31, 2011.